Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

  • There is currently no data for BMK

Contract Win

7 Mar 2017 08:00

RNS Number : 7108Y
Benchmark Holdings PLC
07 March 2017
 

 

RNS Reach

7 March 2017

Benchmark Holdings plc("Benchmark" or the "Company")

 

Contract win for Benchmark

Benchmark announces today that it has signed a long-term agreement with SalMar ASA ("SalMar") to provide genetics, health and knowledge services to the company. The full suite of services the Company is providing illustrates Benchmark's leading position in the market, as well as its ability to offer a wide spread of products and solutions across the salmon's life cycle. SalMar is one of world's leading salmon producers.

Benchmark will, through it's subsidiary SalmoBreed AS, form a 50/50 joint venture for the production of SalMar's salmon strain, Rauma. This joint venture to be called 'SalMar Genetic AS', will be formed by a demerger of SalMar's salmon production facility in Reistad, Norway. Benchmark will take full responsibility for managing the breeding programme through its subsidiary Akvaforsk Genetics Center AS.

The agreement also includes sales of eggs from Benchmark's land based sites in Iceland and once commissioned from its Salten site in Norway. The Benchmark group will also provide fish health services, diagnostics, and health products.

Malcolm Pye, CEO of Benchmark, said;

 

"We are delighted to sign an agreement with such a blue-chip partner in the salmon market. It is testament to our customers' recognition of the benefits of our growing, integrated package of products and services, as well as our ability to enhance value for producers and contribute towards the overall sustainability of the aquaculture industry."

 

 

- ENDS -

 

For further information, please contact:

 

Benchmark Holdings plc

Tel: 020 7920 3150

Malcolm Pye, CEO

Roland Bonney, COO

Rachel Aninakwah, Communications

Numis

Tel: 020 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

James Black (Corporate Broking)

Tavistock

Tel: 020 7920 3150

Niall Walsh / Simon Hudson

 

 

Notes to Editors:

Benchmark challenges the status quo in aquaculture, agriculture and animal healthcare.

 

Since 2000, Benchmark has consistently worked to build a platform to serve its customers, helping farmers to take control of their biological environment through the combination of genetics, nutrition, health and knowledge services. Through its in-depth knowledge of animal biology Benchmark is able to tackle the key issues in the aquaculture, livestock and companion animal sectors.

 

The Company has proven distribution capabilities in high growth markets and operates internationally with R&D facilities, commercial farms, diagnostic laboratories, manufacturing sites, production facilities and commercial offices across 27 countries in five continents. As at 28 February 2017, Benchmark employed 900 people. 

 

For further information on Benchmark please visit www.benchmarkplc.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAJRMRTMBIMMFR
Date   Source Headline
31st Mar 20227:00 amRNSTotal Voting Rights
21st Mar 20227:00 amRNSBlock Listing Six Monthly Return
28th Feb 20229:15 amRNSTotal Voting Rights
22nd Feb 20227:00 amRNSQ1 Results
10th Feb 20225:37 pmRNSResult of AGM
7th Feb 20227:00 amRNSNotice of Q1 Results
4th Feb 20224:41 pmRNSSecond Price Monitoring Extn
4th Feb 20224:36 pmRNSPrice Monitoring Extension
31st Jan 20227:00 amRNSTotal Voting Rights
20th Jan 20227:00 amRNSHolding(s) in Company
31st Dec 20217:00 amRNSTotal Voting Rights
24th Dec 20217:00 amRNSHolding(s) in Company
13th Dec 20213:46 pmRNSHolding(s) in Company
10th Dec 20214:17 pmRNSPosting of Annual Report and Notice of AGM
8th Dec 202112:02 pmRNSDIRECTOR SHARE OPTIONS
2nd Dec 20215:58 pmRNSAnnual Report available on website
1st Dec 202110:12 amRNSHolding(s) in Company
1st Dec 202110:02 amRNSTotal Voting Rights
29th Nov 20212:38 pmRNSPCA Dealing
29th Nov 202110:50 amRNSANNOUNCEMENT REGARDING DIRECTOR SUBSCRIPTIONS
29th Nov 20217:01 amRNSPlacing and Appointment of non-Executive Director
29th Nov 20217:00 amRNSQ4 Results
29th Nov 20217:00 amRNSFull Year Results
12th Nov 20217:00 amRNSInvestor Presentation covering Full Year Results
29th Oct 20217:00 amRNSTotal Voting Rights
18th Oct 20217:00 amRNSTrading Statement
30th Sep 20217:00 amRNSTotal Voting Rights
23rd Sep 20217:00 amRNSEnvironmental recognition for CleanTreat®
21st Sep 20217:00 amRNSBlock Listing Six Monthly Return
31st Aug 20217:00 amRNSTotal Voting Rights
25th Aug 20217:00 amRNSEquity Development Investor Webinar
24th Aug 20217:00 amRNSQ3 Results
30th Jul 20217:00 amRNSTotal Voting Rights
15th Jul 20213:00 pmRNSAdoption of MRL for Ectosan Vet in Norway
2nd Jul 20213:20 pmRNSBMK08+CleanTreat and Trading Update
30th Jun 20217:00 amRNSTotal Voting Rights
21st Jun 20214:41 pmRNSSecond Price Monitoring Extn
21st Jun 20214:36 pmRNSPrice Monitoring Extension
2nd Jun 20214:41 pmRNSSecond Price Monitoring Extn
2nd Jun 20214:35 pmRNSPrice Monitoring Extension
28th May 20217:00 amRNSTotal Voting Rights
25th May 20217:00 amRNSDirector Dealings
18th May 20217:00 amRNSSecond Quarter and Interim results
30th Apr 20217:00 amRNSTotal Voting Rights
19th Apr 20217:00 amRNSNotice of Q2 and Interim Results
16th Apr 202111:00 amRNSBMK08+CleanTreat Update
31st Mar 20213:41 pmRNSDirector Dealings
31st Mar 20217:00 amRNSTotal Voting Rights
30th Mar 20217:00 amRNSListing of existing senior secured NOK bond
26th Mar 20218:24 amRNSBMK08+CleanTreat Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.